Sparsomycin

DB04222ExperimentalSmall molecule

An antitumor antibiotic produced by Streptomyces sparsogenes. It inhibits protein synthesis in 70S and 80S ribosomal systems. [PubChem].

Chemical structure of Sparsomycin
Mechanism
Curator reviewed
Formula / weight
C13H19N3O5S2 · 361.437 g/mol (avg)
Code names
NSC-59729 · SKI 28430 · U-19183

Resolves to

Compound
UNII6C940P63E7CAS1404-64-4ChEMBLCHEMBL105720PubChem9543443
Structure
InChIKeyXKLZIVIOZDNKEQ-CLQLPEFOSA-NSMILESCSC[S@+]([O-])C[C@H](CO)NC(=O)\C=C\C1=C(C)NC(=O)NC1=O

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Sparsomycin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In